Max Healthcare Institute Stock Current Valuation
| MAXHEALTH | 979.75 2.90 0.30% |
Valuation analysis of Max Healthcare Institute helps investors to measure Max Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Max Healthcare's Begin Period Cash Flow is quite stable compared to the past year. Other Cashflows From Investing Activities is expected to rise to about 2.2 B this year, although the value of Other Cashflows From Financing Activities will most likely fall to (2.6 B). Fundamental drivers impacting Max Healthcare's valuation include:
Price Book 10.8244 | Enterprise Value 956.4 B | Enterprise Value Ebitda 54.4386 | Price Sales 15.8522 | Trailing PE 90.0506 |
Undervalued
Today
Please note that Max Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Max Healthcare Institute is based on 3 months time horizon. Increasing Max Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Max stock is determined by what a typical buyer is willing to pay for full or partial control of Max Healthcare Institute. Since Max Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Max Stock. However, Max Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 979.75 | Real 1088.49 | Hype 985.84 | Naive 941.95 |
The intrinsic value of Max Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Max Healthcare's stock price.
Estimating the potential upside or downside of Max Healthcare Institute helps investors to forecast how Max stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Max Healthcare more accurately as focusing exclusively on Max Healthcare's fundamentals will not take into account other important factors: Max Healthcare Institute Company Current Valuation Analysis
Max Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Max Healthcare Current Valuation | 956.38 B |
Most of Max Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Max Healthcare Institute is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Max Healthcare Institute has a Current Valuation of 956.38 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Max Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Max Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Max Healthcare could also be used in its relative valuation, which is a method of valuing Max Healthcare by comparing valuation metrics of similar companies.Max Healthcare is currently under evaluation in current valuation category among its peers.
Max Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0705 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 956.38 B | ||||
| Shares Outstanding | 972.13 M | ||||
| Shares Owned By Insiders | 23.74 % | ||||
| Shares Owned By Institutions | 53.14 % | ||||
| Price To Book | 10.82 X | ||||
| Price To Sales | 15.85 X | ||||
| Revenue | 54.06 B | ||||
| Gross Profit | 27.61 B | ||||
| EBITDA | 16.7 B | ||||
| Net Income | 10.58 B | ||||
| Total Debt | 15.08 B | ||||
| Book Value Per Share | 90.55 X | ||||
| Cash Flow From Operations | 11.22 B | ||||
| Earnings Per Share | 10.88 X | ||||
| Target Price | 1084.75 | ||||
| Number Of Employees | 19.5 K | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 952.45 B | ||||
| Total Asset | 120 B | ||||
| Retained Earnings | 21.89 B | ||||
| Working Capital | 4.57 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 120 B |
About Max Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Max Healthcare Institute's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Max Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Max Healthcare Institute based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Max Stock
Max Healthcare financial ratios help investors to determine whether Max Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Max with respect to the benefits of owning Max Healthcare security.